about
Acetaminophen-induced Liver Injury: from Animal Models to HumansReport from the National Institute of Allergy and Infectious Diseases workshop on drug allergy.New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityCatalytic Properties and Biomedical Applications of Cerium Oxide NanoparticlesBiomonitoring Human Albumin Adducts: The Past, the Present, and the FutureImpact of glutathione S-transferase M1 and T1 on anti-tuberculosis drug-induced hepatotoxicity in Chinese pediatric patientsThe Possible Mechanism of Idiosyncratic Lapatinib-Induced Liver Injury in Patients Carrying Human Leukocyte Antigen-DRB1*07:01Drug-induced liver injury: Advances in mechanistic understanding that will inform risk management.Beyond new chemical entities: advancing drug development based on functional versatility of antibodiesComedications alter drug-induced liver injury reporting frequency: Data mining in the WHO VigiBase™.Insulin-induced localized lipoatrophy preceded by shingles (herpes zoster): a case report.MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury.Molecular docking to identify associations between drugs and class I human leukocyte antigens for predicting idiosyncratic drug reactions.Subtoxic Alterations in Hepatocyte-Derived Exosomes: An Early Step in Drug-Induced Liver Injury?Idiosyncratic Drug-Induced Liver Injury (IDILI): Potential Mechanisms and Predictive Assays.Molecular imaging in gastroenterology.Bioactivation of drugs in the skin: relationship to cutaneous adverse drug reactions.Female gender as a susceptibility factor for drug-induced liver injury.In vitro testing for diagnosis of idiosyncratic adverse drug reactions: Implications for pathophysiology.Recent advances in irreversible kinase inhibitors.Practical approaches to resolving reactive metabolite liabilities in early discovery.Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis.Are drug metabolites able to cause T-cell-mediated hypersensitivity reactions?Immune-mediated diseases: what can be found in the oral cavity?Hepatotoxicity mechanisms of isoniazid: A mini-review.Carbon-carbon bond cleavage and formation reactions in drug metabolism and the role of metabolic enzymes.Human biology-based drug safety evaluation: scientific rationale, current status and future challenges.The pathogenesis of drug-induced liver injury.Drug rechallenge following drug-induced liver injury.Targeted Covalent Inhibitors for Drug Design.Antibiotic-Induced Liver Injury in Paediatric Outpatients: A Case-Control Study in Primary Care Databases.Adverse drug reactions among patients admitted with infectious diseases at a Brazilian hospital.Identification of MHC Haplotypes Associated with Drug-induced Hypersensitivity Reactions in Cynomolgus Monkeys.An 82-year-old man with ataxia and dysarthria.Liver Effects of Clinical Drugs Differentiated in Human Liver Slices.In Silico and In Vitro Analysis of Interaction between Ximelagatran and Human Leukocyte Antigen (HLA)-DRB1*07:01.Definition of the Nature and Hapten Threshold of the β-Lactam Antigen Required for T Cell Activation In Vitro and in Patients.Drug-induced Skin Lesions in Cynomolgus Macaques Treated with Metabotropic Glutamate Receptor 5 (mGluR5) Negative Allosteric Modulators.Quantitative Chemical Proteomic Profiling of the in Vivo Targets of Reactive Drug Metabolites.Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals.
P2860
Q26781944-2B0A69D4-42E2-48DF-A0DA-9A5DA9784EC9Q26800964-946AA44E-F0A9-4B67-9F8E-B9D1FD528DD2Q26800976-E189E181-1673-4F3F-8C69-4414B5C40168Q28383937-E44EEE3D-217C-4483-A035-7B84B5557D73Q28468289-0CEC3619-FB79-4A5B-A2A6-C32C1A43DF51Q28542785-543E4B61-0E1B-40C5-A262-870CEE372642Q28548544-D1C85EAC-F8D2-436E-8122-0F9F0B4376A1Q30241050-0B12E39E-203C-45DB-9C1A-D195E412E600Q30386064-ABBDF8AA-73A8-4084-A52A-391700D3947FQ30954151-494A79A5-3DA7-4442-A46E-1A38FD6AADE3Q33863045-179A14E5-5AEE-41DF-83AB-A8F9AF90BE21Q35750622-0FA72991-333B-4DCC-B8E4-B5EC59FD0ACBQ36089652-D506A2C4-B112-4E47-A202-314D9D644200Q36935435-A9185823-1923-4BD2-9515-2621E13D34ADQ37590883-88118DB2-47CD-4CC3-AE8B-00565B90E362Q38121747-2CC4D7A4-8B80-464C-8502-C8B2368D9DD2Q38155921-B2744AB6-E8A0-4C87-938B-8ED7693832ECQ38168331-470019F3-B232-4236-9F89-2269CF068E0AQ38246967-C827933D-3381-48D2-8027-6BA8683817B5Q38257746-A469FAC8-46E8-46EF-A22D-B275EF3CAEF7Q38269781-773B932D-07FE-4AC4-A582-E902D4029E9AQ38271339-A81DEBF7-48EB-4431-8143-4C941A77F19AQ38286229-E232D25C-F47E-4DF6-88C7-3D7789AAC6F1Q38290659-6E1434BD-D260-49DD-B918-30EC416834DDQ38533596-392037A3-6190-4649-AD7E-F9C113CF3553Q38590451-E52A12CD-FCD1-435E-A977-3201C2FEE241Q38763000-489CFB54-8209-4445-ACB7-EB4066F5CC8EQ38849978-DCFA12D2-CC52-4657-B66D-9CCBA5CDF8A3Q38906878-396C92AB-851A-4F8F-AEA5-61AD781AEEBEQ38931379-C0A980AC-0116-40BE-9092-49B979A3C686Q39063027-3892F9A0-897C-43DD-AB66-1D5C27F80828Q39078108-505EC0BE-A605-441A-B2E3-FFF01728AC01Q39159544-68B3CAEC-8720-4AC6-85EA-284ACDB1AE51Q40954118-DEB3AD0C-D9A0-4894-8DC6-FA1DB0E3478DQ41951728-494243AC-CF7E-402D-9D2E-3913E0D1AEA7Q42289978-634DD7F0-3FDD-4EDB-8BB5-89E487D540D3Q45193633-6CD7184E-1B0C-435D-AB5A-09431F03007AQ46030428-0187786F-B83C-4B73-A222-0FA72C97810EQ46847239-926109C7-2F8C-4E52-9C71-04F829D88833Q47116954-10E1123E-C1B0-4667-813A-04071028FF27
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Idiosyncratic adverse drug reactions: current concepts
@ast
Idiosyncratic adverse drug reactions: current concepts
@en
Idiosyncratic adverse drug reactions: current concepts
@nl
type
label
Idiosyncratic adverse drug reactions: current concepts
@ast
Idiosyncratic adverse drug reactions: current concepts
@en
Idiosyncratic adverse drug reactions: current concepts
@nl
prefLabel
Idiosyncratic adverse drug reactions: current concepts
@ast
Idiosyncratic adverse drug reactions: current concepts
@en
Idiosyncratic adverse drug reactions: current concepts
@nl
P2860
P356
P1476
Idiosyncratic adverse drug reactions: current concepts
@en
P2093
D. J. Naisbitt
J. Uetrecht
P2860
P304
P356
10.1124/PR.113.007450
P407
P577
2013-04-01T00:00:00Z